Introduction What is CAR T-Cell Therapy? Currently Approved CAR T-Cell Therapies Reasons for Reduced Efficacy of CAR T-Cell Therapy Acute and Long-Term Adverse Effects of CAR T-Cell Therapy Secondary Myeloid Malignancies and CAR T-Cell Therapy CAR T-Cell Therapy for Solid Malignant Tumors Tumor-Infiltrating Lymphocytes (TILs) TIL Therapy and Solid Malignant Tumors TCR T-Cell Therapy and Solid Malignant Tumors Future Developments: CAR NK Cells Conclusions References

Related articles Order reprints Share article Share by email